Epicream versus Elidel for treatment of mild to moderate atopic dermatitis

Journal of Drugs in Dermatology, Feb, 2008

Sponsored by: Ceragenix Pharmaceuticals. The objective of this study is to determine whether Epicream (ceramide based barrier repair cream is a safe and effective therapy for mild to moderate atopic dermatitis and whether it may serve as an alternative to Elidel therapy.

Condition   Intervention                       Phase

Atopic      Drug: Elidel[R] (pimecrolimus 1%)  Phase IV
Dermatitis  Device: EpiCream[R]

Study ID Numbers: CGXP--060674/IRB00002569

ClinicalTrials.gov Identifier: NCT00460083